View of Infection Risk Associated with Low Dose Rituximab in Primary Autoimmune Hemolytic Anaemia: Mechanisms, Outcomes, and Clinical Management

Return to Article Details Infection Risk Associated with Low Dose Rituximab in Primary Autoimmune Hemolytic Anaemia: Mechanisms, Outcomes, and Clinical Management Download Download PDF